THE WORLD PRACTICE IN THE ASSESSMENT OF THE INTERCHANGEABILITY OF BIOENGINEERED DRUGS
- 作者: Smirnov V.1, Krasnykh L.2, Merkulov V.2, Bunyatyan N.1, Ramenskaya G.1, Yeltsova E.2, Smolyarchuk E.3, Yegorenkov E.3, Bushmanova A.3
-
隶属关系:
- cientific Centre for Expert Evaluation of Medicinal Products of the Ministry of Health of the Russian Federation, I.M. Sechenov First Moscow State Medical University
- Scientific Centre for Expert Evaluation of Medicinal Products of the Ministry of Health of the Russian Federation
- M. Sechenov First Moscow State Medical University
- 期: 卷 26, 编号 9 (2015)
- 页面: 12-14
- 栏目: Articles
- URL: https://journals.eco-vector.com/0236-3054/article/view/116372
- ID: 116372
如何引用文章
详细
全文:
![受限制的访问](https://journals.eco-vector.com/lib/pkp/templates/images/icons/text_lock.png)
作者简介
V. Smirnov
cientific Centre for Expert Evaluation of Medicinal Products of the Ministry of Health of the Russian Federation, I.M. Sechenov First Moscow State Medical University
Email: Bunyatyan@expmed.ru
L. Krasnykh
Scientific Centre for Expert Evaluation of Medicinal Products of the Ministry of Health of the Russian Federation
Email: Bunyatyan@expmed.ru
V. Merkulov
Scientific Centre for Expert Evaluation of Medicinal Products of the Ministry of Health of the Russian Federation
Email: Bunyatyan@expmed.ru
N. Bunyatyan
cientific Centre for Expert Evaluation of Medicinal Products of the Ministry of Health of the Russian Federation, I.M. Sechenov First Moscow State Medical University
Email: Bunyatyan@expmed.ru
G. Ramenskaya
cientific Centre for Expert Evaluation of Medicinal Products of the Ministry of Health of the Russian Federation, I.M. Sechenov First Moscow State Medical University
Email: Bunyatyan@expmed.ru
E. Yeltsova
Scientific Centre for Expert Evaluation of Medicinal Products of the Ministry of Health of the Russian Federation
Email: Bunyatyan@expmed.ru
E. Smolyarchuk
M. Sechenov First Moscow State Medical University
Email: Bunyatyan@expmed.ru
E. Yegorenkov
M. Sechenov First Moscow State Medical University
Email: Bunyatyan@expmed.ru
A. Bushmanova
M. Sechenov First Moscow State Medical University
Email: Bunyatyan@expmed.ru
参考
- На мировом фармрынке доминируют биопрепараты URL:http://www. pharmvestnik.ru/publs/lenta/obzory/na-mirovom-farmrynke-dominirujut- biopreparaty.html#.U0wwBFV_tc0
- Об обращении лекарственных средств [Электронный ресурс]: Федеральный закон от 12.04.2010 №61-ФЗ (ред. от 12.03.2014). Доступ из справ.-правовой системы «КонсультантПлюс»
- Федеральный закон от 22.12.2014 №429 «О внесении изменения в Федеральный закон «Об обращении лекарственных средств» / Министерство здравоохранения Российской Федерации [официальный сайт]. URL: http:// rosminzdrav.ru/docs/mzsr/projects/1926
- Biosimilars: anoverview. URL:file:///C:/Documents%20and%20Settings/ Admin/%D0%9C%D0%BE%D0%B8%20%D0%B4%D0%BE%D0%BA%D1%83%D 0%BC%D0%B5%D0%BD%D1%82%D1%8B/Downloads/3deec51aecf8dc7a73.pdf
- Annex to Guideline on Similar Biological Medicinal Products Containing Biotechnology derived Proteins as Drug Substance - Non Clinical and Clinical Issues containing Recombinant Granulocyte Colony-Stimulating Factor, CHMP/31329/05, February 2006. URL: www.ema.europa.eu/pdfs/human/ biosimilar/3132905en
- Annex to Guideline on Similar Biological Medicinal Products Containing Biotechnology derived Proteins as Drug Substance - Non Clinical and Clinical Issues containing Recombinant Human Erythropoietin, CHMP/94526/05, March 2006. URL: www.ema.europa.eu/pdfs/human/biosimilar/9452605en. Accessed 02 September 2010
- Annex to Guideline on Similar Biological Medicinal Products Containing Biotechnology derived Proteins as Drug Substance- Non Clinical and Clinical Issues containing Recombinant Human Growth Hormone, CHMP/94528/05, February 2006. URL: www.ema.europa.eu/pdfs/human/biosimilar/9452805en
- Guideline on Immunogenicity Assessment of Biotechnology-derived Therapeutic Proteins. EMEA/CHMP/BMWP/14327/2006, December 2007. URL:http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_ guideline/2009/09/WC500003946.pdf
- Guideline on non-clinical and clinical development of similar biological medicinal products containing recombinant human insulin and insulin analogues EMEA/CHMP/BMWP/32775/2005_Rev., December 2012. URL:http://www.ema. europa.eu/docs/en_GB/document_library/Scientific_guideline/2012/12/ WC500136392.pdf
- Guideline on Similar Biological MedicinalProducts, CPMP/437/04, October 2005. URL: http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_ guideline/2009/09/WC500003517.pdf (дата обращения 14.04.2014)
- Guidelineon Similar Biological Medicinal Products Containing Biotechnology- derived Proteins as Drug Substance - Non Clinical and Clinical Issues, EMEA/ CHMP/BMWP/42832/05, February 2006. URL: http://www.triskel.com/2%20 Guideline%20biotech%20derived%20proteins.pdf
- Guideline on Similar Biological MedicinalProducts containing biotechnology- derived proteins as active substance: quality issues (revision 1). EMA, Committee for Medicinal Products for Human Use, 2012. URL:http://www.ema.europa.eu/ docs/en_GB/document_library/Scientific_guideline/2012/05/WC500127960.pdf (дата обращения 14.04.2014)
- Guideline on Similar Biological Medicinal Products Containing Low- molecular Weight Heparins. Draft released for consultation in April 2008. URL: www.ema.europa.eu/pdfs/human/biosimilar/11826407en
- Guideline on similar biological medicinal products containing monoclonal antibodies - non-clinical and clinical issues, CHMP/BMWP/403543/2010, May 2012. URL:http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_ guideline/2012/06/WC500128686.pdf
- Guideline on similar biological medicinal products containing recombinant interferon alpha, CHMP/BMWP/102046/2006, October 2007. URL:http://www.ema. europa.eu/docs/en_GB/document_library/Scientific_guideline/2009/09/ WC500003931.pdf
- IMS Health 2007 & 2009, Evaluate Pharma, Sandoz analysis
- Jenkins N., Murphy L., Tyther R. Post-translational modifications of recombinant proteins: significance for biopharmaceuticals // Mol. Biotechnol. - 2008; 39: 113-8
- Misra A. Are biosimilars really generics? // Expert Opin. Biol. Ther. - 2010; 10 (4): 489-94
- Sahoo N., Choudhury K., Manchikanti P. Manufacturing of biodrugs: need for harmonization in regulatory standards // Biodrugs. - 2009; 23: 217-29
- The Commission of the European Communities (2003) Commission Directive 2003/63/EC of 25 June 2003 amending Directive 2001/83/EC of the European Parliament and of the Council on the Community code relating to medicinal products for human use // In Official Journal of the European Union. - L159. - Р. 46-94
- The European Parliament and the Council of the European Union (2004) Directive 2004/27/EC of the European Parliament and of the Council of 31 March 2004 amending Directive 2001/83/EC on the Community code relating to medicinal products for human use // In Official Journal of the European Union. - L136, pp. 34-57
补充文件
![](/img/style/loading.gif)